Prime Time for Immunotherapy in Advanced Urothelial Cancer

Asia-Pacific Journal of Clinical Oncology - United Kingdom
doi 10.1111/ajco.13059
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Sipuleucel-T: Immunotherapy for Advanced Prostate Cancer

Research and Reports in Urology
Urology
2011English

Cabozantinib in Combination With Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives

Cancers
Cancer ResearchOncology
2011English

Stereotactic Body Radiotherapy for Prostate Cancer: Ready for Prime Time?

Journal of Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2012English

Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy

Applied Immunohistochemistry and Molecular Morphology
Forensic MedicinePathologyMedical Laboratory TechnologyHistology
2016English

Sequential Methotrexate and 5-Fluorouracil, Doxorubicin, and Cisplatin for Advanced Urothelial Cancer

Japanese Journal of Urology
Urology
1992English

Nonmuscle Invasive Urothelial Cancer— Bacillus Calmette–Guérin Instillation or Checkpoint Inhibitor Immunotherapy?

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-Vac) in Advanced Urothelial Cancer

Japanese Journal of Urology
Urology
1991English

Management of Incidental Nodules in Lung Cancer Screening: Ready for Prime-Time?

Breathe
PulmonaryRespiratory Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy